Free Trial

YS Biopharma (YSBPW) Competitors

$0.04 -0.01 (-14.36%)
As of 04/17/2025

YSBPW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying YS Biopharma stock or one of its competitors? The main competitors of YS Biopharma include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

YS Biopharma vs.

180 Life Sciences (NASDAQ:ATNFW) and YS Biopharma (NASDAQ:YSBPW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, community ranking, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled YS Biopharma'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
YS Biopharma Neutral

180 Life Sciences and YS Biopharma both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
YS BiopharmaN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
YS Biopharma$560.76MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
YS Biopharma N/A N/A N/A

Summary

YS Biopharma beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get YS Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for YSBPW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

YSBPW vs. The Competition

MetricYS BiopharmaBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$121.10M$5.31B$7.35B
Dividend YieldN/A3.75%5.45%4.29%
P/E RatioN/A3.0521.9417.81
Price / SalesN/A4,230.36380.9597.68
Price / CashN/A13.1938.2634.64
Price / BookN/A34.276.453.98
Net IncomeN/A-$91.73M$3.22B$247.81M
1 Month PerformanceN/A-5.05%-9.76%-7.91%
1 Year PerformanceN/A84.00%11.49%1.53%

YS Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
YSBPW
YS Biopharma
N/A$0.04
-14.4%
N/A-48.4%$0.00$560.76M0.00865Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-12.5%
N/A-20.2%$0.00N/A0.007
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
+8.0%
N/A-50.2%$0.00$607,574.000.002Positive News
Gap Up
DRTSW
Alpha Tau Medical
N/A$0.21
+2.7%
N/A-6.3%$0.00N/A0.0080Positive News
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
flat
N/A-56.8%$0.00N/A0.0059Short Interest ↓
Positive News
BCTXW
BriaCell Therapeutics
N/A$0.08
-16.8%
N/A-93.2%$0.00N/A0.008Gap Down
CDIOW
Cardio Diagnostics
N/A$0.03
+16.1%
N/A-66.5%$0.00$34,890.000.007Short Interest ↑
Positive News
Gap Up
CTCXW
Carmell
N/A$0.03
+6.8%
N/A-66.6%$0.00$32,839.000.0014Gap Up
CELUW
Celularity
N/A$0.04
-9.8%
N/A+17.6%$0.00$48.20M0.00220
CEROW
CERo Therapeutics
N/A$0.01
+15.8%
N/A-85.7%$0.00N/A0.008Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:YSBPW) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners